Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.14 HKD
866.91 M HKD
2.86 B HKD
406.16 M
About CONSUN PHARMACEUTICAL GRP LIMITED
Sector
CEO
Meng An
Headquarters
Guangzhou
Website
Founded
1997
FIGI
BBG005P67Y41
Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through the Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium. The Yulin Pharmaceutical segment retails traditional Chinese medicines. The company was founded by Qian Li in 1997 and is headquartered in Guangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1681 is 7.79 HKD — it has increased by 2.91% in the past 24 hours. Watch CONSUN PHARMACEUTICAL GRP LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CONSUN PHARMACEUTICAL GRP LIMITED stocks are traded under the ticker 1681.
1681 stock has fallen by −1.64% compared to the previous week, the month change is a −6.82% fall, over the last year CONSUN PHARMACEUTICAL GRP LIMITED has showed a 65.74% increase.
We've gathered analysts' opinions on CONSUN PHARMACEUTICAL GRP LIMITED future price: according to them, 1681 price has a max estimate of 12.30 HKD and a min estimate of 9.80 HKD. Watch 1681 chart and read a more detailed CONSUN PHARMACEUTICAL GRP LIMITED stock forecast: see what analysts think of CONSUN PHARMACEUTICAL GRP LIMITED and suggest that you do with its stocks.
1681 reached its all-time high on May 29, 2018 with the price of 9.75 HKD, and its all-time low was 2.61 HKD and was reached on Mar 19, 2020. View more price dynamics on 1681 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1681 stock is 3.59% volatile and has beta coefficient of 0.57. Track CONSUN PHARMACEUTICAL GRP LIMITED stock price on the chart and check out the list of the most volatile stocks — is CONSUN PHARMACEUTICAL GRP LIMITED there?
Today CONSUN PHARMACEUTICAL GRP LIMITED has the market capitalization of 6.47 B, it has decreased by −6.26% over the last week.
Yes, you can track CONSUN PHARMACEUTICAL GRP LIMITED financials in yearly and quarterly reports right on TradingView.
CONSUN PHARMACEUTICAL GRP LIMITED is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
1681 net income for the last half-year is 433.19 M HKD, while the previous report showed 471.72 M HKD of net income which accounts for −8.17% change. Track more CONSUN PHARMACEUTICAL GRP LIMITED financial stats to get the full picture.
CONSUN PHARMACEUTICAL GRP LIMITED dividend yield was 9.43% in 2023, and payout ratio reached 41.05%. The year before the numbers were 7.41% and 29.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 3.13 K employees. See our rating of the largest employees — is CONSUN PHARMACEUTICAL GRP LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONSUN PHARMACEUTICAL GRP LIMITED EBITDA is 971.30 M HKD, and current EBITDA margin is 32.59%. See more stats in CONSUN PHARMACEUTICAL GRP LIMITED financial statements.
Like other stocks, 1681 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONSUN PHARMACEUTICAL GRP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONSUN PHARMACEUTICAL GRP LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONSUN PHARMACEUTICAL GRP LIMITED stock shows the buy signal. See more of CONSUN PHARMACEUTICAL GRP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.